Literature DB >> 17574383

Comparative in vitro cytotoxicity assessment of selected gaseous compounds in human alveolar epithelial cells.

S Bakand1, C Winder, A Hayes.   

Abstract

Exposure to airborne contaminants is significantly associated with human health risks, ranging from bronchial reactivity to morbidity and mortality due to acute intense or long term low level repeated exposures. However, the precise mechanisms that derive such effects are not always understood. Although inhalation studies are technologically complicated, correct hazard characterisation is essential for comparable risk assessment of inhaled materials. The aim of this study was to investigate the comparative in vitro cytotoxicity of selected gaseous contaminants in human lung cells. The cytotoxicity of nitrogen dioxide (NO(2)), sulphur dioxide (SO(2)) and ammonia (NH(3)) was investigated in A549- human pulmonary type II-like epithelial cell lines cultured on porous membranes in Snapwell inserts. A dynamic direct exposure method was established by utilizing the horizontal diffusion chamber system (Harvard Apparatus Inc, USA) for delivery of test atmospheres. Test atmospheres were generated using a dynamic direct dilution method and the concentration monitored by appropriate analytical methods. A diversified battery of in vitro assays including the MTS (tetrazolium salt; Promega), NRU (neutral red uptake; Sigma) and ATP (adenosine triphosphate; Promega) assays was implemented. Airborne IC(50) (50% inhibitory concentration) values were calculated based on the most sensitive assay for each test gas including NO(2) (IC(50)=11+/-3.54 ppm; NRU)>SO(2) (IC(50)=48+/-2.83 ppm; ATP)> and NH(3) (IC(50)=199+/-1.41 ppm; MTS). However, all in vitro assays revealed similar toxicity ranking for selected gaseous contaminants. Identical toxicity ranking was achieved using both in vitro and published in vivo data. This comparison suggests that results of in vitro methods are comparable to in vivo data and may provide greater sensitivity for respiratory toxicity studies of gaseous contaminants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574383     DOI: 10.1016/j.tiv.2007.04.013

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  The Development of an In Vitro Horizontal Diffusion Cell to Monitor Nasal Powder Penetration Inline.

Authors:  Péter Gieszinger; Tamás Kiss; Piroska Szabó-Révész; Rita Ambrus
Journal:  Pharmaceutics       Date:  2021-05-28       Impact factor: 6.321

2.  Cytotoxicity of selenium nanoparticles in rat dermal fibroblasts.

Authors:  Joseph F Ramos; Thomas J Webster
Journal:  Int J Nanomedicine       Date:  2012-07-23

3.  Validation of the dynamic direct exposure method for toxicity testing of diesel exhaust in vitro.

Authors:  Lucky Joeng; Amanda Hayes; Shahnaz Bakand
Journal:  ISRN Toxicol       Date:  2013-08-05

Review 4.  Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles.

Authors:  Shahnaz Bakand; Amanda Hayes
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

5.  Influence of wood species on toxicity of log-wood stove combustion aerosols: a parallel animal and air-liquid interface cell exposure study on spruce and pine smoke.

Authors:  Tuukka Ihantola; Sebastiano Di Bucchianico; Mikko Happo; Mika Ihalainen; Oskari Uski; Stefanie Bauer; Kari Kuuspalo; Olli Sippula; Jarkko Tissari; Sebastian Oeder; Anni Hartikainen; Teemu J Rönkkö; Maria-Viola Martikainen; Kati Huttunen; Petra Vartiainen; Heikki Suhonen; Miika Kortelainen; Heikki Lamberg; Ari Leskinen; Martin Sklorz; Bernhard Michalke; Marco Dilger; Carsten Weiss; Gunnar Dittmar; Johannes Beckers; Martin Irmler; Jeroen Buters; Joana Candeias; Hendryk Czech; Pasi Yli-Pirilä; Gülcin Abbaszade; Gert Jakobi; Jürgen Orasche; Jürgen Schnelle-Kreis; Tamara Kanashova; Erwin Karg; Thorsten Streibel; Johannes Passig; Henri Hakkarainen; Jorma Jokiniemi; Ralf Zimmermann; Maija-Riitta Hirvonen; Pasi I Jalava
Journal:  Part Fibre Toxicol       Date:  2020-06-15       Impact factor: 9.400

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.